Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Respir Med ; 181: 106384, 2021 05.
Article in English | MEDLINE | ID: mdl-33839587

ABSTRACT

BACKGROUND: While lung ultrasonography (LUS) has utility for the evaluation of the acute phase of COVID-19 related lung disease, its role in long-term follow-up of this condition has not been well described. The objective of this study is to compare LUS and chest computed tomography (CT) results in COVID-19 survivors with the intent of defining the utility of LUS for long-term follow-up of COVID-19 respiratory disease. METHODS: Prospective observational study that enrolled consecutive survivors of COVID-19 with acute hypoxemic respiratory failure (HARF) admitted to the Respiratory Intensive Care Unit. Three months following hospital discharge, patients underwent LUS, chest CT, body plethysmography and laboratory testing, the comparison of which forms the basis of this report. RESULTS: 38 patients were enrolled, with a total of 190 lobes analysed: men 27/38 (71.1%), mean age 60.6 y (SD 10.4). LUS findings and pulmonary function tests outcomes were compared between patients with and without ILD, showing a statistically significant difference in terms of LUS score (p: 0.0002), FEV1 (p: 0.0039) and FVC (p: 0.012). ROC curve both in lobe by lobe and in patient's overall analysis revealed an outstanding ILD discrimination ability of LUS (AUC: 0.94 and 0.95 respectively) with a substantial Cohen's coefficient (K: 0.74 and 0.69). CONCLUSIONS: LUS has an outstanding discrimination ability compared to CT in identifying an ILD of at least mild grade in the post COVID-19 follow-up. LUS should be considered as the first-line tool in follow-up programs, while chest CT could be performed based on LUS findings.


Subject(s)
COVID-19/diagnostic imaging , Lung/diagnostic imaging , Respiratory Insufficiency/diagnostic imaging , Survivors , Ultrasonography , Aged , COVID-19/complications , Female , Follow-Up Studies , Humans , Lung Diseases, Interstitial/diagnostic imaging , Lung Diseases, Interstitial/etiology , Male , Middle Aged , Prospective Studies , Respiratory Function Tests , Respiratory Insufficiency/etiology , Time Factors , Tomography, X-Ray Computed
2.
Appl Spectrosc ; 70(1): 186-96, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26767644

ABSTRACT

To date, little attention has been given to the scientific investigation of modern and contemporary mural paintings. This paper reports on: (1) the in situ spectroscopic analyses of the mural Tuttomondo (1989) painted by Keith Haring (1958-1990) in Pisa (Italy); and (2) the laboratory characterization of acrylic paints produced by Caparol Italy GmbH & Co., the original supplier of paint materials to the artist for the mural. Ultraviolet (UV), visible (Vis), and near-infrared (NIR) fiber optic reflectance spectroscopy (FORS) measurements were carried out in situ. The Caparol paint samples were characterized using benchtop instrumentation including both dispersive and Fourier transform Raman spectroscopy, Fourier transform infrared spectroscopy (FT-IR; with sample pre-treatment to remove filler interference in the fingerprint region), and UV-Vis-NIR FORS. This combined analytical approach confirmed that the materials used by Haring for the mural Tuttomondo have the same composition of the new Caparol acrylic paints, except for the case of the yellow pigment. This information offers valuable documentation for the materials history and for the conservation of a mural painting that is considered the last great public work by Haring.

SELECTION OF CITATIONS
SEARCH DETAIL
...